Research Update: ConvaTec Healthcare B S.a.r.l. Placed On CreditWatch Positive On IPO Plan; New Term Loan Rated Preliminary 'BB' - S&P Global Ratings’ Credit Research

Research Update: ConvaTec Healthcare B S.a.r.l. Placed On CreditWatch Positive On IPO Plan; New Term Loan Rated Preliminary 'BB'

Research Update: ConvaTec Healthcare B S.a.r.l. Placed On CreditWatch Positive On IPO Plan; New Term Loan Rated Preliminary 'BB' - S&P Global Ratings’ Credit Research
Research Update: ConvaTec Healthcare B S.a.r.l. Placed On CreditWatch Positive On IPO Plan; New Term Loan Rated Preliminary 'BB'
Published Oct 03, 2016
6 pages (1899 words) — Published Oct 03, 2016
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

ConvaTec Healthcare B S.a.r.l. has announced intentions to file an initial public offering (IPO). We anticipate the company will use proceeds from the IPO to repay approximately $900 million in paid-in-kind (PIK) notes and pay off its Euro-denominated term loan B, U.S.-dollar-denominated term loan B, and unsecured notes, which will lead to a meaningful improvement in its credit measures. We also expect the company to convert its preferred equity certificates (PECs) to common equity Pro forma for the IPO, we expect the capital structure to consist of a $200 million senior secured revolver, $1.125 billion in new Euro/USD senior secured term loan A, and a $585 million of U.S.-dollar-denominated senior secured term loan B; all of this debt will be

  
Brief Excerpt:

...We anticipate the company will use proceeds from the IPO to repay approximately $900 million in paid-in-kind (PIK) notes and pay off its Euro-denominated term loan B, U.S.-dollar-denominated term loan B, and unsecured notes, which will lead to a meaningful improvement in its credit measures. We also expect the company to convert its preferred equity certificates (PECs) to common equity...

  
Report Type:

Research Update

Issuer
Sector
Global Issuers
Country
Region
United States
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: ConvaTec Healthcare B S.a.r.l. Placed On CreditWatch Positive On IPO Plan; New Term Loan Rated Preliminary 'BB'" Oct 03, 2016. Alacra Store. May 14, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-ConvaTec-Healthcare-B-S-a-r-l-Placed-On-CreditWatch-Positive-On-IPO-Plan-New-Term-Loan-Rated-Preliminary-BB-1729036>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: ConvaTec Healthcare B S.a.r.l. Placed On CreditWatch Positive On IPO Plan; New Term Loan Rated Preliminary 'BB' Oct 03, 2016. New York, NY: Alacra Store. Retrieved May 14, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-ConvaTec-Healthcare-B-S-a-r-l-Placed-On-CreditWatch-Positive-On-IPO-Plan-New-Term-Loan-Rated-Preliminary-BB-1729036>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.